|
YTHDF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.418900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.071580E-02 |
| Normal-vs-Stage2 |
5.010300E-02 |
| Normal-vs-Stage3 |
2.701100E-03 |
| Normal-vs-Stage4 |
1.62937999999002E-05 |
| Stage1-vs-Stage2 |
9.736000E-01 |
| Stage1-vs-Stage3 |
3.904800E-01 |
| Stage1-vs-Stage4 |
1.507720E-02 |
| Stage2-vs-Stage3 |
5.694400E-01 |
| Stage2-vs-Stage4 |
5.326500E-02 |
| Stage3-vs-Stage4 |
1.006590E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.876900E-03 |
| Normal-vs-AfricanAmerican |
1.587570E-01 |
| Normal-vs-Asian |
2.183500E-02 |
| Caucasian-vs-AfricanAmerican |
5.915600E-01 |
| Caucasian-vs-Asian |
8.689800E-01 |
| AfricanAmerican-vs-Asian |
6.953000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.483000E-03 |
| Normal-vs-Female |
2.620100E-03 |
| Male-vs-Female |
7.798400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.430360E-02 |
| Normal-vs-Age(41-60Yrs) |
9.377300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.282800E-03 |
| Normal-vs-Age(81-100Yrs) |
4.178000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.849800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.997000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.113000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.781000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.396200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.612800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.031800E-02 |
| Classical-VS-Follicular |
1.920470E-03 |
| Classical-VS-Other |
9.450000E-02 |
| Classical-VS-Normal |
5.782400E-02 |
| Tall-VS-Follicular |
9.881400E-01 |
| Tall-VS-Other |
5.121400E-01 |
| Tall-VS-Normal |
9.793700E-04 |
| Follicular-VS-Other |
5.818800E-01 |
| Follicular-VS-Normal |
2.753700E-04 |
| Other-VS-Normal |
1.156170E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.390800E-04 |
| Normal-vs-N1 |
1.240740E-04 |
| N0-vs-N1 |
1.394230E-01 |
|
|
